Compounds > 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide
Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Ischemia

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Ischemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bird, JE; Durham, SK; Giancarli, MR; Liu, EC; Wasserman, AJ; Webb, ML1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Ischemia

ArticleYear
Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia.
    Pharmacology, 1995, Volume: 50, Issue:1

    Topics: Animals; Blood Pressure; Creatinine; Dansyl Compounds; Endothelin Receptor Antagonists; Glomerular Filtration Rate; Glycopeptides; Iodine Radioisotopes; Ischemia; Kidney; Male; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Time Factors

1995